Leaflet DIBASE 300.000UI / ml solution for injection

Product code:
W67599001
Quantity:
2
Indicated for:
calcium deficiency; osteoporosis
Route of administration:
injectable
Substance:
cholecalciferol (vitamin)
ATC
A11CC05 — Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues
Cholecalciferol, also known as vitamin D3, is a form of vitamin D used for the prevention and treatment of vitamin D deficiency. It is essential for bone health as it aids in the absorption of calcium and phosphorus from food, preventing conditions such as rickets in children and osteomalacia or osteoporosis in adults.

Cholecalciferol is indicated in cases of vitamin D deficiency, for fracture prevention, and in the treatment of hypocalcemia associated with hypoparathyroidism. It is available in capsules, tablets, oral drops, or injectable solutions.

Side effects are rare but may include nausea, constipation, excessive thirst, or hypercalcemia (high calcium levels in the blood) in cases of overdose. It is contraindicated in patients with hypercalcemia, hypervitaminosis D, or severe renal impairment.

General data about DIBASE 300.000UI / ml

Substance:
cholecalciferol
Date of latest medicines list:
01-06-2023
Product code:
W67599001
Concentration:
300.000UI / ml
Pharmaceutical form:
solution for injection
Quantity:
2
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ABIOGEN PHARMA S.P.A. - ITALIA
Holder:
IMECO S.A. - ROMANIA
Number:
593/2021/01
Shelf life:
3 years

Pharmaceutical forms available for cholecalciferol

Concentrations available for cholecalciferol

  • 0.45mg/ml
  • 0.5mg/ml
  • 100.000UI/ml
  • 10000UI
  • 1000UI
  • 14400UI/ml
  • 18000UI/ml
  • 200000UI/ml
  • 20000UI
  • 20000UI/ml
  • 300.000UI/ml
  • 30000UI
  • 5000UI
  • 500UI
  • 7000UI